"The Asia Pacific in situ hybridization market is segmented into product, technology, application, end user, and country. The FISH segment is expected to witness significant growth during the forecast period due to
"In March 2023, Agilent Technologies, Inc. (US) acquired e-MSion (US). Through this acquisition, Agilent will integrate the e-MSion's ExD cell into its portfolio of advanced workflows, instruments, and analytical
The global in vitro toxicology testing market in terms of revenue was estimated to be worth $10.8 billion in 2023 and is poised to reach $17.1 billion by 2028, growing at a CAGR of 9.5% from 2023 to 2028.
/PRNewswire/ The In Vitro Toxicology Testing industry is poised for a transformative evolution in the near future, driven by advancements in technology,.